A61P 43 - Drugs for specific purposes, not provided for in groups

Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/2006
11/15/2006	EP1007514B1 Heterocyclic ketones as npy y5 antagonists
11/15/2006	EP0969836B1 Lactose-free, non-hygroscopic and anhydrous pharmaceutical compositions of descarboethoxyloratadine
11/15/2006	EP0968206B1 N-heterocyclic derivatives as nos inhibitors
11/15/2006	EP0799032B1 Pharmacologic management of snoring
11/15/2006	CN1864434A Wireless microphone communication system
11/15/2006	CN1863803A 嘧啶衍生物 Pyrimidine derivatives
11/15/2006	CN1863784A 2-naphthylimino-1,3-thiazine derivative
11/15/2006	CN1863783A Compounds having thrombopoietin receptor agonism
11/15/2006	CN1863779A Novel indazole derivative
11/15/2006	CN1863543A Dietetic composition
11/15/2006	CN1863526A Collagen productin enhancer and production process and use thereof
11/15/2006	CN1861555A Triphenylalkene derivatives and their use as selective estrogen receptor modulators
11/15/2006	CN1861151A Oral liquor for heatstroke-prevention
11/15/2006	CN1861140A Compound Chinese lobelia Tea agent and its prepn. method
11/15/2006	CN1861137A Compound semisolid prepn. contg. Chinese lobelia for external use and its prepn. method
11/15/2006	CN1861127A Compound lobelia oral liquid prepn. and its prepn. method
11/15/2006	CN1861125A Prepn. method for compound lobelia fog-like prepn.
11/15/2006	CN1861117A High performance anidrotic umbilicus plaster
11/15/2006	CN1861114A Application of Qishen Yidripping pills for preparing medicine for preventing and treating high-altitude oxygen deficit
11/15/2006	CN1861113A Application of Qishen Yiqi dripping pills for preparing medicine to inhibit degranulation of labrocyte
11/15/2006	CN1861112A Application of Qishen Yiqi dripping pills for preparing medicine to inhibit leakage of albumin
11/15/2006	CN1861109A Compound medicine for improving tolerance of oxygen deficit, and its prepn. method
11/15/2006	CN1861098A Calmophil, pharmaceutical composition and producing method
11/15/2006	CN1861097A Deer blood wine
11/15/2006	CN1861096A Application of diarsenic trioxide in ion-exchange protein
11/15/2006	CN1861077A Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/15/2006	CN1861059A Hydrophilic gel type percutaneous plaster contg. capsaicin, and its prepn. method
11/15/2006	CN1284859C Membrane virus host range mutations and their uses as vaccine substrates
11/15/2006	CN1284793C C-aryl glucoside sglt2 inhibitors
11/15/2006	CN1284783C Substituted nitrogen contg. heterocycles as inhibitors of P38 progein kinase
11/15/2006	CN1284781C Polycyclic compounds having anti-tumor activity
11/15/2006	CN1284780C 8'4-'3-(5-fluoro-1H-indol-3-yl)propyl!-1-piperazinyl!-2-methyl-2H-1,4-benzoxazin -3(4H)-one methanesulfonate with high affinity for the dopamine D2 receptor and the seotonin reuptake site
11/15/2006	CN1284777C 5-membered heterocycles, preparation and use thereof as medicine
11/15/2006	CN1284771C TNF－α生成抑制剂 TNF-α production inhibitor
11/15/2006	CN1284536C Application of tetrodotoxin or saxitionxin and analogs thereof in preparation of general antalgic medicine application
11/15/2006	CN1284522C Dextrose and insulin fluid formulation for intravenous infusion
11/14/2006	US7135600 Selective beta 2-adrenoreceptor agonists; rapid onset of action, long duration; such as 3-(4-{[6-{(-2-hydroxy-2-[4-hydroxy-3-(hydroxymethyl)phenyl]ethyl}amino)hexyl]oxy}butyl)benzenesulfonamide; synthesis
11/14/2006	US7135587 Such as 3-biphenyl-4-yl-3-(2-(3-(pyridin-2-ylamino)pro-poxycarbonylamino) -ethanoylamino)propionic acid; thromboses, cardiac infarction, coronary heart disease, arteriosclerosis, inflammation, tumors. osteoporosis, infections, restenosis
11/14/2006	US7135586 Biphenylcarboxamides useful as lipid lowering agents
11/14/2006	US7135572 Diaryl 1,2,4-triazole derivatives as a highly selective cyclooxygenase-2 inhibitor
11/14/2006	US7135571 Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
11/14/2006	US7135501 Clusianon isomers and use thereof
11/14/2006	US7135491 5-Aryltetrazole compounds and uses thereof
11/14/2006	US7135489 Cyclooxygenase inhibitors; antiinflammatory agents
11/14/2006	US7135486 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and the use thereof
11/14/2006	US7135483 Substituted heterocyclic compounds for treating multidrug resistance
11/14/2006	US7135477 Administering N-(2-[N',N'-diethylamino]-5-[N''-(4-fluorophenylsulfonyl)-N''-propargylamino]pyrimidin-4-yl)-4'-(pyrrolidin-1-ylcarbonyloxy)-L-phenylalanine as an antiinflammatory agent treating rheumatoid arthritis
11/14/2006	US7135475 Antidiabetic agents
11/14/2006	US7135474 In combination with organic nitrate or nitric oxide donors or inhibitors of cyclic GMP metabolism; erectile dysfunction or female sexual dysfunction
11/14/2006	US7135473 Cyclic diamine compound with condensed-ring groups
11/14/2006	US7135471 Aryl oximes
11/14/2006	US7135466 used in the treatment of diseases mediated by the autophosphorylation of a PDGF receptor, specifically, compounds which can inhibit neointima formation hypertrophy.
11/14/2006	US7135464 Method of administering decitabine
11/14/2006	US7135321 Truncated glycogen synthase kinase 3 crystallizable polypeptide; drug screening for Alzheimer's Disease treatments, antidiabetic and antiinflammatory agents
11/14/2006	US7135189 Compositions and techniques for localized therapy
11/14/2006	US7135182 Administration of substrates for transglutaminases or antibodies against such substrates; identification, prevention or treatment of microbial infection of mammalian hosts such as immunocompromised or immunosuppressed humans
11/14/2006	US7135177 Immunoliposomes that optimize internalization into target cells
11/14/2006	CA2417887C Particulate composition of eletriptan
11/14/2006	CA2379572C Polymorphic salt
11/14/2006	CA2342271C Gem substituted hydroxamic acids
11/14/2006	CA2340320C Use of an angiogenic factor for the treatment of microascular angiopathies
11/14/2006	CA2294783C Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
11/14/2006	CA2263846C Novel pyranoside derivatives
11/14/2006	CA2214072C Benzo [b] thiophene compounds, intermediates, processes, compositions, and methods
11/14/2006	CA2128955C Tricyclic benzazepine vasopressin antagonists
11/14/2006	CA2128493C Aminobenzoic acid derivatives
11/14/2006	CA2100812C Substituted aminothienopyridines, a process for their preparation and their use as medicaments
11/14/2006	CA2040410C Wound healing compositions containing il-1 and a growth factor
11/13/2006	CA2790058A1 Herceptin® adjuvant therapy
11/13/2006	CA2540547A1 Herceptin adjuvant therapy
11/09/2006	WO2006118341A1 Novel lactam compound
11/09/2006	WO2006118328A1 Degranulation inhibitor
11/09/2006	WO2006118320A1 Thienopyrimidone compound
11/09/2006	WO2006118307A1 Therapeutic agent for pain
11/09/2006	WO2006118299A1 Gpcr inhibitor
11/09/2006	WO2006118256A1 2-aminoquinazoline derivatives
11/09/2006	WO2006118231A1 Cyanopyridine derivative and use thereof as medicine
11/09/2006	WO2006118212A1 Agent for preventing and treating pancreatitis
11/09/2006	WO2006118173A1 Trenadermal absorption preparation
11/09/2006	WO2006118169A1 Antiasthmatic drug comprising pgd2 receptor antagonist and leukotriene receptor antagonist
11/09/2006	WO2006118079A1 Antiaging agnet for skin
11/09/2006	WO2006117925A1 METHOD AND DEVICE FOR REGENERATING PANCREATIC β-CELLS
11/09/2006	WO2006117029A1 Use of polylysine in combination with either green tea or olive extracts or both for use against halitosis
11/09/2006	WO2006083947A3 Compositions and methods for treating fibrotic disorders
11/09/2006	WO1998035042A8 Activity dependent neurotrophic factor iii (adnf iii)
11/09/2006	US20060253912 Nucleotide and amino acid sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
11/09/2006	US20060252934 For treatment of asthma, allergies, inflammation and anxiety; antihistamines; sedatives; tranquilizing agents
11/09/2006	US20060252839 Cyclopenteneones for antiischemic agents, antiinflammatory agents and aging resistance
11/09/2006	US20060252833 Improve efficiency when administered with conventional drugs; side effect reduction; Parkinson's disease therapy; administering a fatty acid
11/09/2006	US20060252822 Mitochrondrial permeability transition pore affinity labels and modulators
11/09/2006	US20060252814 Formulation comprising a betablocker and optionally a cholestrol-lowering agent
11/09/2006	US20060252813 Apparatus for curing a composite laminate
11/09/2006	US20060252810 e.g. 5-(4-Fluorophenyl)-4-(4-pyridinyl)imidazole-2-thio-3-propyl-N-phthalimide; immunomodulating and cytokine-release-inhibiting action; antiinflammatory agent
11/09/2006	US20060252806 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006	US20060252805 synergistic use of angiotensin II receptor antagonist like (5-methyl-2-oxo-1,3-dioxolen-4-yl)methyl 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazol-5-carboxylate with the calcium channel blockers; calcium channel blockers containing 1,4-dihydropyridine group
11/09/2006	US20060252799 Benzo (F) insoindol derivatives and their use as EP4 receptor ligands
11/09/2006	US20060252797 Receptor regulator
11/09/2006	US20060252793 Useful as adjuvants to chemotherapy or radiation therapy to treat cancer; as inhibitors of checkpoint kinase Cds1 (in man also known as Chk2); 2-[4-(3,4-dichloro-phenoxy)-phenyl]-1H-imidazo[4,5-b]pyridine-5-carboxylic acid amide
11/09/2006	US20060252792 Immunology for viral diseases and biosynthesis of cytokines of anticancer drugs for tumors
11/09/2006	US20060252769 Obesity, type 2 diabetes, sleep disorders, ischaemic or haemorrhagic strokes, antiemetic; toxicity; side effect reduction; 2-((benzofuran-4-yl)carbonylaminomethyl)-1-((4-(5-(4-fluorophenyl)-2-methyl)thiazolyl)carbonyl)-4-methylpiperazine

1 ... 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 ... 1564